This inventor holds 2 USPTO granted patents. Top assignee: The Green Cross Corporation. Active years: 1986-1987.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1986-1987
Title: The Innovations of Shirou Komeda
Introduction
Shirou Komeda is a notable inventor based in Tondabayashi, Japan. He has made significant contributions to the field of medical technology, particularly in the development of injectable solutions and drug delivery systems. With a total of 2 patents, his work has the potential to impact the treatment of various medical conditions.
Latest Patents
One of his latest patents is an injectable aqueous solution containing hydrogensulfite and/or sulfite. This solution is effective for controlling local injuries such as inflammation and vein injury that may occur during the injection of antitumor benzodiazepine compounds. The formulation includes an alkali metal hydrogensulfite or sulfite, which can be administered by injection to provide therapeutic benefits.
Another significant patent is for a fibronectin-dextran-drug complex and the method of preparation thereof. This complex allows drugs, such as antitumor agents or antibiotics, to be preferentially delivered to morbid parts, such as injured tissues or tumor sites. The preparation involves reacting the drug with an oxidized dextran and fibronectin, enhancing the targeted delivery of therapeutic agents.
Career Highlights
Shirou Komeda is associated with The Green Cross Corporation, where he continues to innovate in the field of medical solutions. His work is characterized by a focus on improving drug delivery methods and enhancing patient outcomes through advanced formulations.
Collaborations
He has collaborated with notable coworkers, including Yasuo Ueda and Yoshio Kagitani, contributing to the advancement of medical technologies and innovations.
Conclusion
Shirou Komeda's contributions to the field of medical technology through his patents demonstrate his commitment to improving healthcare solutions. His innovative approaches have the potential to significantly enhance treatment options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
